Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 158 days ( -1.86 % )
Last Price $8.22 0 %
High/ Low $8.22 - $8.22 0%
Chg 7 Days N/A $8.22 $8.22
Chg 30 Days N/A $8.22 $8.22
Chg 12 mos 62.45 % $5.06 $8.22
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 71.93 % Width: 45.75 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $12.70 - $18.51 54.53 % - 125.24 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2021-11-22 - 130 days
Long MA avg 12 mos Buy 2021-10-08 - 161 days
Short/Long MA avg 12 mos Buy 2021-10-08 - 161 days
Pivot Short Sell 2022-05-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT